The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License ...

Keytruda has been approved since 2016 as a second-line option after chemotherapy for patients with more advanced HNSCC that ...

Reported EPS is $1.76, expectations were $1.17. John McCartney: Good morning, and welcome to Scotiabank’s 2025 First Quarter ...

Q4 2024 Earnings Call Transcript February 25, 2025 CCC Intelligent Solutions Holdings Inc. reports earnings inline with ...